INCAGI004
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://data.mendeley.com/datasets/75vdm7phv9
下载链接
链接失效反馈官方服务：
资源简介：
Randomized controlled trial comparing two neoadjuvant chemotherapy regimes for locally advanced rectal cancer. Stage II and III rectal cancer patients were randomized to receive neoCRT with either capecitabine (Group 1) or 5-Fu and leucovorin (Group 2) concomitant to long course radiotherapy. Clinical downstaging was accessed using MRI 6-8 weeks after treatment. EORTCs QLQ C30 and CR38 were applied before treatment (T0), after neoCRT (T1), after rectal resection (T2), early after adjuvant chemotherapy (T3), and one year after end of treatment or stoma closure (T4). Wexner scale was used for continence evaluation at T4. A C30SummaryScore (Geisinger et cols) was calculated to compare QOL results.
创建时间：
2021-09-27
